These echo the recent findings derived primarily from mouse models by Zong et al.57 that TIGIT is critical in adaptive immunotolerance to HBV and Ostroumov et al.58 that TIGIT represents an important T cell exhaustion marker in liver cancer and its expression can more reliably identify exhausted CD8 T cells as compared to PD-1. Here, TIGIT is linked to liver cancer.